|

KITE-363 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Kite, A Gilead Company1

Indications

  • Chronic Inflammatory Demyelinating Polyneuropathy1
  • Multiple Sclerosis1
  • Myasthenia Gravis1
  • Cancer1

Salt Lake City, Utah1 trial

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

LDS Hospital - Intermountain Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.